Squarepoint’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Squarepoint’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,684	Closed	-$255K	–	3617
2022 Q1	$255K	Buy	+13,684	New	+$246K	﹤0.01%	2372
2021 Q4	–	Sell	-11,980	Closed	-$221K	–	3673
2021 Q3	$221K	Buy	+11,980	New	+$241K	﹤0.01%	2428

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Squarepoint's OCDX Position: Q2 2022 in Review

Squarepoint sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 13,684 shares — an estimated $255K sold.

Squarepoint first reported a position in OCDX in Q3 2021 and held it in 2 quarters. The position peaked at $255K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Squarepoint reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Squarepoint sold 13,684 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $255K.
Squarepoint first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 2 quarters.
Squarepoint's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $255K in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Squarepoint's 13F filing for Q2 2022, filed 15 Aug 2022.